Intellectual Disability in Episodic Ataxia Type 2: Beyond Paroxysmal Vertigo and Ataxia

다국어 초록 (Multilingual Abstract)

Background and Purpose Episodic ataxia type 2 (EA2) is characterized by recurrent vertigo and ataxia due to mutations in CACNA1A that encodes the α1A-subunit of the P/Q-type voltage-gated calcium channel. This study aimed to determine intellectual function in EA2.
Methods During 2019–2023, 13 patients (6 males, age range=10–52 years, median age=29 years) with a genetically confirmed diagnosis of EA2 had their intellectual function evaluated using the Korean versions of the Wechsler Intelligence Scales (version IV) for adults or children in 3 referral-based university hospitals in South Korea.
Results The full-scale intelligence quotients (FSIQs) among the 13 patients were below the average (90–109) in 11, low average (80–89) in 5 (38.5%), borderline (70–79) in 1 (7.7%), and indicated intellectual disability (≤69) in 5 (38.5%). These patterns of cognitive impairments were observed in all four of the following subtests: verbal comprehension, perceptual reasoning, working memory, and processing speed. The FSIQ was not correlated with the ages at onset for vertigo and ataxia (Pearson correlation: p=0.40).
Conclusions Patients with EA2 may have hidden intellectual disabilities even without a history of epilepsy or administration of antiepileptic drugs, and should be considered for genetic counseling and therapeutic interventions. Given the availability of medication to control episodic vertigo and ataxia, early diagnosis and management are important in preventing irreversible brain dysfunction in EA2.

참고문헌 (Reference)

• 1 Wechsler D, "Wechsler Adult Intelligence Scale–Fourth Edition(WAISIV)" NCS Pearson 2008
• 2 Burgess DL, "Voltage-dependent calcium channel mutations in neurological disease" 868 : 199-212, 1999
• 3 Choi JH, "Vestibular impairments in episodic ataxia type 2" 269 : 2687-2695, 2022
• 4 Kim S, "Vertical saccadic slowing in episodic ataxia type 2" 18 : 726-728, 2022
• 5 Jung EJ, "Validity of the K-WAIS-IV short forms : focused on clinical utility" 5 : 213-231, 2019
• 6 Jacobi H, "Update cerebellum and cognition" 268 : 3921-3925, 2021
• 7 Spacey SD, "Two novel CACNA1A gene mutations associated with episodic ataxia type 2 and interictal dystonia" 62 : 314-316, 2005
• 8 Strupp M, "Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine" 62 : 1623-1625, 2004
• 9 Ilyas M, "The genetics of intellectual disability : advancing technology and gene editing" 9 (9): 22-, 2020
• 10 Hommersom MP, "The complexities of CACNA1A in clinical neurogenetics" 269 : 3094-3108, 2022
• 11 Ducros A, "The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel" 345 : 17-24, 2001
• 12 Schmahmann JD, "The cerebellum and cognition" 688 : 62-75, 2019
• 13 Sokolov AA, "The cerebellum : adaptive prediction for movement and cognition" 21 : 313-332, 2017
• 14 Guerin AA, "Stepwise developmental regression associated with novel CACNA1A mutation" 39 : 363-364, 2008
• 15 Shimmura M, "Slowed abduction during smooth pursuit eye movement in episodic ataxia type 2 with a novel CACNA1A mutation" 381 : 4-6, 2017
• 16 Sim NL, "SIFT web server : predicting effects of amino acid substitutions on proteins" 40 (40): W452-W457, 2012
• 17 Lee SU, "Recurrent spontaneous vertigo with interictal headshaking nystagmus" 90 : e2135-e2145, 2018
• 18 Choi KD, "Recovery of vestibular imbalances after vestibular neuritis" 117 : 1307-1312, 2007
• 19 Kim HJ, "Rebound upbeat nystagmus after lateral gaze in episodic ataxia type 2" 13 : 411-413, 2014
• 20 Yue Q, "Progressive ataxia due to a missense mutation in a calcium-channel gene" 61 : 1078-1087, 1997
• 21 Jen JC, "Primary episodic ataxias : diagnosis, pathogenesis and treatment" 130 : 2484-2493, 2007
• 22 Shevell M, "Practice parameter : evaluation of the child with global developmental delay : report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society" 60 : 367-380, 2003
• 23 Choi KD, "Possible anticipation associated with a novel splice site mutation in episodic ataxia type 2" 34 : 1629-1632, 2013
• 24 Jung J, "Phenotypic variability of episodic ataxia type 2 mutations : a family study" 64 : 114-116, 2010
• 25 Feeney GF, "Paroxysmal cerebellar ataxia" 19 : 113-117, 1989
• 26 Kipfer S, "Novel CACNA1A mutation(s)associated with slow saccade velocities" 260 : 3010-3014, 2013
• 27 Steinhaus R, "MutationTaster2021" 49 (49): W446-W451, 2021
• 28 Lee SU, "Lower brainstem melanocytoma masquerading as vestibular paroxysmia" 265 : 1222-1225, 2018
• 29 Jeon S, "Korean Genome Project: 1094 Korean personal genomes with clinical information" 6 : eaaz7835-, 2020
• 30 Rucker JC, "Internuclear ophthalmoparesis in episodic ataxia type 2" 1039 : 571-574, 2005
• 31 Davydov EV, "Identifying a high fraction of the human genome to be under selective constraint using GERP++" 6 : e1001025-, 2010
• 32 Jouvenceau A, "Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel" 358 : 801-807, 2001
• 33 Denier C, "High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2" 52 : 1816-1821, 1999
• 34 Mochizuki Y, "Hereditary paroxysmal ataxia with mental retardation : a clinicopathological study in relation to episodic ataxia type 2" 108 : 345-349, 2004
• 35 Griggs RC, "Hereditary paroxysmal ataxia : response to acetazolamide" 28 : 1259-1264, 1978
• 36 Choi KD, "Genetic variants associated with episodic ataxia in Korea" 7 : 13855-, 2017
• 37 Rajakulendran S, "Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy" 588 : 1905-1913, 2010
• 38 Spacey SD, "Functional implications of a novel EA2 mutation in the P/Q-type calcium channel" 56 : 213-220, 2004
• 39 Indelicato E, "From genotype to phenotype : expanding the clinical spectrum of CACNA1A variants in the era of next generation sequencing" 12 : 639994-, 2021
• 40 Hawkes CH, "Familial paroxysmal ataxia : report of a family" 55 : 212-213, 1992
• 41 Ophoff RA, "Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4" 87 : 543-552, 1996
• 42 Baloh RW, "Familial episodic ataxia : clinical heterogeneity in four families linked to chromosome 19p" 41 : 8-16, 1997
• 43 Lee SU, "Evolution in the findings of head-impulse tests during the attacks of menière’s disease" 41 : e744-e750, 2020
• 44 Ka M, "Essential roles for ARID1B in dendritic arborization and spine morphology of developing pyramidal neurons" 36 : 2723-2742, 2016
• 45 van den Maagdenberg AM, "Episodic ataxia type 2. Three novel truncating mutations and one novel missense mutation in the CACNA1A gene" 249 : 1515-1519, 2002
• 46 Jodice C, "Episodic ataxia type 2(EA2)and spinocerebellar ataxia type 6(SCA6)due to CAG repeat expansion in the CACNA1A gene on chromosome 19p" 6 : 1973-1978, 1997
• 47 Kim JM, "Episodic ataxia type 2 due to a deletion mutation in the CACNA1A gene in a Korean family" 2 : 268-271, 2006
• 48 Nachbauer W, "Episodic ataxia type 2 : phenotype characteristics of a novel CACNA1A mutation and review of the literature" 261 : 983-991, 2014
• 49 Verriello L, "Epilepsy and episodic ataxia type 2 : family study and review of the literature" 268 : 4296-4302, 2021
• 50 Van Overwalle F, "Consensus paper : cerebellum and social cognition" 19 : 833-868, 2020
• 51 Bohne P, "Cognitive deficits in episodic ataxia type 2 mouse models" 30 : 1811-1832, 2021
• 52 Jen J, "Clinical spectrum of episodic ataxia type 2" 62 : 17-22, 2004
• 53 Lipman AR, "Clinical and genetic characterization of CACNA1A-related disease" 102 : 288-295, 2022
• 54 Yang Y, "Cerebellar hypoperfusion during transient global amnesia : an MRI and oculographic study" 5 : 74-80, 2009
• 55 Choi JY, "Central paroxysmal positional nystagmus : characteristics and possible mechanisms" 84 : 2238-2246, 2015
• 56 Clapham DE, "Calcium signaling" 131 : 1047-1058, 2007
• 57 Mintz IM, "Calcium control of transmitter release at a cerebellar synapse" 15 : 675-688, 1995
• 58 Jen J, "Calcium channelopathies in the central nervous system" 9 : 274-280, 1999
• 59 Damaj L, "CACNA1A haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms" 23 : 1505-1512, 2015
• 60 Vahedi K, "CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy" 55 : 1040-1042, 2000
• 61 Lee SH, "Benign paroxysmal positional vertigo" 6 : 51-63, 2010
• 62 Huh YE, "Bedside evaluation of dizzy patients" 9 : 203-213, 2013
• 63 Zhuchenko O, "Autosomal dominant cerebellar ataxia(SCA6)associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel" 15 : 62-69, 1997
• 64 Bigelow RT, "Association between vertigo, cognitive and psychiatric conditions in US children : 2012 National Health Interview Survey" 130 : 109802-, 2020
• 65 Missiaen L, "Abnormal intracellular ca(2+)homeostasis and disease" 28 : 1-21, 2000
• 66 Mallmann RT, "Ablation of Ca(V)2. 1 voltage-gated Ca(2+)channels in mouse forebrain generates multiple cognitive impairments" 8 : e78598-, 2013
• 67 Jen J, "A novel nonsense mutation in CACNA1A causes episodic ataxia and hemiplegia" 53 : 34-37, 1999
• 68 Park D, "A novel CACNA1A mutation associated with episodic ataxia 2 presenting with periodic paralysis" 118 : 137-139, 2018
• 69 Adzhubei IA, "A method and server for predicting damaging missense mutations" 7 : 248-249, 2010
• 70 Vahedi K, "A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19p" 37 : 289-293, 1995
• 71 Halmagyi GM, "A clinical sign of canal paresis" 45 : 737-739, 1988